A carregar...
The First Frontier: Digital Biomarkers for Neurodegenerative Disorders
Current measures of neurodegenerative diseases are highly subjective and based on episodic visits. Consequently, drug development decisions rely on sparse, subjective data, which have led to the conduct of large-scale phase 3 trials of drugs that are likely not effective. Such failures are costly, d...
Na minha lista:
| Publicado no: | Digit Biomark |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7015357/ https://ncbi.nlm.nih.gov/pubmed/32095743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000477383 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|